Henry Schein Stock: Analysts' Current Sentiment

2 min read | November 25, 2024 04:25 AM PST | By Team Kalkine Media

Henry Schein Stock: Analysts' Current Sentiment — Image source: Shutterstock

Article:

Henry Schein, Inc.,(NASDAQ:HSIC) based in Melville, New York, is a leading provider of health care products and services, catering to dental practitioners, physician practices, ambulatory surgery centers, government institutions, and other healthcare facilities. The company offers a wide range of products, from dental and medical solutions to operational and clinical services designed to improve outcomes and operational success. With a market capitalization of $9.4 billion, Henry Schein is one of the world’s largest healthcare solutions providers.

Over the past year, Henry Schein’s stock has underperformed the broader market, gaining just 8.2% compared to the S&P 500 Index’s nearly 31% rise. In 2024, HSIC shares have seen a slight decline, while the S&P 500 Index has posted a 25.2% increase year-to-date. Furthermore, when compared to the performance of the SPDR S&P Health Care Services ETF (XHS), which has gained approximately 11.8% over the past year and 7.4% year-to-date, Henry Schein’s performance appears relatively weak.

The company’s lackluster performance can be attributed to several factors. A decline in sales of personal protective equipment, notably reduced glove pricing, has impacted revenue. Additionally, lingering effects from a cyber incident that occurred late in the previous year have contributed to the company’s struggles.

Henry Schein reported its third-quarter results on November 5, with adjusted earnings per share (EPS) of $1.22, surpassing Wall Street’s consensus estimate of $1.16. However, the company’s revenue for the quarter was $3.17 billion, falling short of the $3.24 billion forecast. For the full year, Henry Schein expects its adjusted EPS to range between $4.74 and $4.82.

Despite recent challenges, analysts remain moderately positive about Henry Schein’s outlook. The consensus among 13 analysts covering the stock is a "Moderate Buy," with a mix of strong buy, hold, and sell ratings.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.